Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
Lothar C. Dieterich, Kristian Ikenberg, Timur Cetintas, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Kabir A. Khan, Robert S. Kerbel
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 5, pp. 310-324
Closed Access | Times Cited: 530
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Marco B.E. Schaaf, Abhishek D. Garg, Patrizia Agostinis
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 521
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi, Timothy A. Chan, Guido Kroemer, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 459
Open Access | Times Cited: 493
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Rebekka Weber, Viktor Fleming, Xiaoying Hu, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 474
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto, Francheska Caminero, Lindsay Cash, et al.
Translational Oncology (2020) Vol. 13, Iss. 3, pp. 100738-100738
Open Access | Times Cited: 235
Dormant tumour cells, their niches and the influence of immunity
Erica T. Goddard, Ivana Božić, Stanley R. Riddell, et al.
Nature Cell Biology (2018) Vol. 20, Iss. 11, pp. 1240-1249
Closed Access | Times Cited: 163
Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
Yang Liu, Xiaojia Liu, Na Zhang, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 12, pp. 2299-2312
Open Access | Times Cited: 160
Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
Amy L. Shergold, Rhona Millar, Robert J. B. Nibbs
Pharmacological Research (2019) Vol. 145, pp. 104258-104258
Open Access | Times Cited: 147
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
Tetiana Hourani, James A. Holden, Wenyi Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 116
Lymphatic vessels in cancer
Lothar C. Dieterich, Carlotta Tacconi, Luca Ducoli, et al.
Physiological Reviews (2022) Vol. 102, Iss. 4, pp. 1837-1879
Closed Access | Times Cited: 84
Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1143-1143
Open Access | Times Cited: 53
Targeting endothelial permeability in the EPR effect
Behnaz Lahooti, Racheal G. Akwii, Fatema Tuz Zahra, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 212-235
Closed Access | Times Cited: 43
Cardiac lymphatics in health and disease
Ebba Bråkenhielm, Kari Alitalo
Nature Reviews Cardiology (2018) Vol. 16, Iss. 1, pp. 56-68
Closed Access | Times Cited: 161
IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
Ryan S. Lane, Julia Femel, Alec P. Breazeale, et al.
The Journal of Experimental Medicine (2018) Vol. 215, Iss. 12, pp. 3057-3074
Open Access | Times Cited: 143
Growth and Immune Evasion of Lymph Node Metastasis
Dennis Jones, Ethel R. Pereira, Timothy P. Padera
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 130
The dark side of tumor-associated endothelial cells
Francesco De Sanctis, Stefano Ugel, John G. Facciponte, et al.
Seminars in Immunology (2018) Vol. 35, pp. 35-47
Closed Access | Times Cited: 108
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
Katharina Maisel, Maria Stella Sasso, Lambert Potin, et al.
Advanced Drug Delivery Reviews (2017) Vol. 114, pp. 43-59
Open Access | Times Cited: 106
Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels
Chenfei Zhou, Wen-Fei Wei, Jing Ma, et al.
Molecular Therapy (2021) Vol. 29, Iss. 4, pp. 1512-1528
Open Access | Times Cited: 99
Tumor-Associated Lymphatic Vessel Features and Immunomodulatory Functions
Laure Garnier, Anastasia‐Olga Gkountidi, Stéphanie Hugues
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 98
The evolving role of lymphatics in cancer metastasis
Rae H. Farnsworth, Marc G. Achen, Steven A. Stacker
Current Opinion in Immunology (2018) Vol. 53, pp. 64-73
Closed Access | Times Cited: 88
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy
Jiyong Liang, Lulu Wang, Chao Wang, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 7, pp. 952-965
Open Access | Times Cited: 84
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
Antonella Sistigu, Martina Musella, Claudia Galassi, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 83
Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment
Chenfei Zhou, Yanmei Zhang, Rui-Ming Yan, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 2, pp. 715-729
Open Access | Times Cited: 78
Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels
Stanley P. L. Leong, Kamila Naxerova, Laura Keller, et al.
Clinical & Experimental Metastasis (2021) Vol. 39, Iss. 1, pp. 159-179
Open Access | Times Cited: 72
The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance
Kangchen Chen, Chenzhi Zhang, Sunbin Ling, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 9
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top